Cat.#: ACPP-1477
| Despition | I TAC Mouse Recombinant |
| SIZE | 5 µg |
| Purity | > 98.0% (SDS-PAGE) |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1818 | Mouse FGF 9 Protein (AC1818) | 2 µg | inquiry |
| ACPP-1442 | Human TBCB Protein (AC1442) | 5 µg | inquiry |
| ACPP-1829 | Human SNAPIN Protein (AC1829) | 10 µg | inquiry |
| ACPP-1334 | DRP1 Blocking Peptide (AC1334) | 250 µg | inquiry |
| ACPP-1429 | Human FGF14 Protein (AC1429) | 2 µg | inquiry |
| ACPP-1438 | Human NDRG2 Protein (AC1438) | 5 µg | inquiry |
| ACPP-1208 | beta Catenin Blocking Peptide (AC1208) | 250 µg | inquiry |
| ACPP-1276 | MAP3K4 Blocking Peptide (AC1276) | 250 µg | inquiry |
| ACPP-1450 | Human BMP13 Protein (AC1450) | 10 µg | inquiry |
| ACPP-1259 | Usherin Blocking Peptide (AC1259) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.